6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Retinopathy of Prematurity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chemtob, S; Dembinska, O; Dorfman, AL; Lachapelle, P | 1 |
| Bullard, LE; Penn, JS; Tolman, BL | 1 |
2 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Retinopathy of Prematurity
| Article | Year |
|---|---|
Structural and functional consequences of trolox C treatment in the rat model of postnatal hyperoxia.
Topics: Animals; Animals, Newborn; Antioxidants; Chromans; Disease Models, Animal; Electroretinography; Humans; Hyperoxia; Infant, Newborn; Oxygen; Rats; Rats, Sprague-Dawley; Retina; Retinopathy of Prematurity | 2006 |
Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity.
Topics: Animals; Animals, Newborn; Antioxidants; Capillaries; Chromans; Dextrans; Disease Models, Animal; Fluorescein; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Infant, Newborn; Injections, Intraperitoneal; Ink; Oxygen; Rats; Rats, Sprague-Dawley; Retina; Retinopathy of Prematurity | 1997 |